UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

March 18, 2020

Date of Report (Date of earliest event reported)

AVVAA WORLD HEALTH CARE PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

Nevada		000-31611		88-395714
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification No.)

Box 459, 1710 Shuswap Ave, Lumby A1		V0E 2G0
(Address of principal executive offices)		(Zip Code)

407-284-5470

(Registrant's telephone number)

__________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
◻	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
◻	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
◻	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

Effective March 18, 2020, the Board of Directors (the “Board”) of Avvaa World Health Care Products, Inc., a Nevada corporation (the “Company”) appointed Dr. Jun Wang to serve as a member of the Board of Directors. Mr.Wang brings a diverse background in banking and academia. His new position as director will be to locate and execute acquisitions/mergers for the company moving forward.

Signatures

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	AVVAA WORLD HEALTH CARE PRODUCTS, INC.

DATED: March 18, 2020	By:	Stephanie Willet
		Stephanie Willet
		Interim-President (Principal Executive Officer)

AVVAA WORLD HEALTH CARE PRODUCTS INC 8-K